{
    "2021-07-05": [
        [
            {
                "time": "",
                "original_text": "金域医学(603882.SH)股东君睿祺及一致行动人减持比例达1% 减持期届满 减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "一致行动人",
                        "减持",
                        "1%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学：君睿祺及君联茂林减持计划实施完毕，共减持约463万股",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "君联茂林",
                        "减持",
                        "463万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)：股东君睿祺及君联茂林累计减持1.0011%股份 减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "君联茂林",
                        "减持",
                        "1.0011%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学：君睿祺及君联茂林合计减持1%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "君联茂林",
                        "减持",
                        "1%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：全方位盘点上半年医药行业、细分领域、个股风云变幻",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "上半年",
                        "盘点",
                        "风云变幻"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业动态：系统性调整不改长期向好趋势",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "系统性调整",
                        "长期向好趋势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业每周医览药闻：关注结构性机会 把握高确定性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "结构性机会",
                        "高确定性"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}